PubMed:21628852
Annnotations
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 184-215 | HP_0002092 | denotes | pulmonary arterial hypertension |
| T2 | 203-215 | HP_0000822 | denotes | hypertension |
| T3 | 380-407 | HP_0001871 | denotes | hematological abnormalities |
| T4 | 409-420 | HP_0000155 | denotes | oral ulcers |
| T5 | 426-441 | HP_0001041 | denotes | facial erythema |
| T6 | 433-441 | HP_0010783 | denotes | erythema |
| T7 | 558-581 | HP_0001973 | denotes | immune thrombocytopenia |
| T8 | 565-581 | HP_0001873 | denotes | thrombocytopenia |
| T9 | 661-670 | HP_0000123 | denotes | nephritis |
| T10 | 952-959 | HP_0002094 | denotes | dyspnea |
| T11 | 952-971 | HP_0002875 | denotes | dyspnea on exertion |
| T12 | 1090-1111 | HP_0005180 | denotes | tricuspid regurgitant |
| T13 | 1267-1282 | HP_0001907 | denotes | thromboembolism |
| T14 | 1369-1392 | HP_0005180 | denotes | tricuspid regurgitation |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_21628852_1_0 | 184-215 | expanded | denotes | pulmonary arterial hypertension |
| SS2_21628852_1_0 | 217-220 | abbr | denotes | PAH |
| SS1_21628852_1_1 | 269-299 | expanded | denotes | systematic lupus erythematosus |
| SS2_21628852_1_1 | 301-304 | abbr | denotes | SLE |
| SS1_21628852_4_0 | 655-670 | expanded | denotes | lupus nephritis |
| SS2_21628852_4_0 | 672-674 | abbr | denotes | LN |
| SS1_21628852_5_0 | 835-863 | expanded | denotes | intravenous cyclophosphamide |
| SS2_21628852_5_0 | 865-869 | abbr | denotes | IVCY |
| SS1_21628852_7_0 | 1188-1213 | expanded | denotes | brain natriuretic peptide |
| SS2_21628852_7_0 | 1215-1218 | abbr | denotes | BNP |
| AE1_21628852_1_0 | SS1_21628852_1_0 | SS2_21628852_1_0 | abbreviatedTo | pulmonary arterial hypertension,PAH |
| AE1_21628852_1_1 | SS1_21628852_1_1 | SS2_21628852_1_1 | abbreviatedTo | systematic lupus erythematosus,SLE |
| AE1_21628852_4_0 | SS1_21628852_4_0 | SS2_21628852_4_0 | abbreviatedTo | lupus nephritis,LN |
| AE1_21628852_5_0 | SS1_21628852_5_0 | SS2_21628852_5_0 | abbreviatedTo | intravenous cyclophosphamide,IVCY |
| AE1_21628852_7_0 | SS1_21628852_7_0 | SS2_21628852_7_0 | abbreviatedTo | brain natriuretic peptide,BNP |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 42-60 | http://purl.obolibrary.org/obo/UBERON_0002012 | denotes | pulmonary arterial |
| PD-UBERON-AE-B_T2 | 184-202 | http://purl.obolibrary.org/obo/UBERON_0002012 | denotes | pulmonary arterial |
| PD-UBERON-AE-B_T3 | 1014-1032 | http://purl.obolibrary.org/obo/UBERON_0002012 | denotes | pulmonary arteries |
| PD-UBERON-AE-B_T4 | 52-60 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
| PD-UBERON-AE-B_T5 | 194-202 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
| PD-UBERON-AE-B_T6 | 1024-1032 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arteries |
| PD-UBERON-AE-B_T7 | 690-695 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T8 | 736-741 | http://purl.obolibrary.org/obo/UBERON_0001088 | denotes | urine |
| PD-UBERON-AE-B_T9 | 1040-1045 | http://purl.obolibrary.org/obo/UBERON_0001443 | denotes | chest |
| PD-UBERON-AE-B_T10 | 1188-1193 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T11 | 1291-1295 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
PubCasesHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 184-215 | HP:0002092 | denotes | pulmonary arterial hypertension |
| TI1 | 127-136 | HP:0000123 | denotes | nephritis |
| AB2 | 409-420 | HP:0000155 | denotes | oral ulcers |
| AB3 | 426-441 | HP:0001041 | denotes | facial erythema |
| AB4 | 565-581 | HP:0001873 | denotes | thrombocytopenia |
| AB5 | 661-670 | HP:0000123 | denotes | nephritis |
| AB6 | 952-959 | HP:0002094 | denotes | dyspnea |
| AB7 | 1267-1282 | HP:0001907 | denotes | thromboembolism |
| AB8 | 1369-1392 | HP:0005180 | denotes | tricuspid regurgitation |
PubCasesORDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 558-581 | ORDO:3002 | denotes | immune thrombocytopenia |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-138 | Sentence | denotes | [Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis]. |
| TextSentencer_T2 | 139-306 | Sentence | denotes | We report a 43-year-old female who developed pulmonary arterial hypertension (PAH) during intensive immunosuppressive therapy for systematic lupus erythematosus (SLE). |
| TextSentencer_T3 | 307-442 | Sentence | denotes | She was diagnosed as SLE at the age of 32 years based on serological and hematological abnormalities, oral ulcers, and facial erythema. |
| TextSentencer_T4 | 443-605 | Sentence | denotes | She experienced frequent flare-ups of disseminated discoid lupus between the ages of 33 and 36 years and developed immune thrombocytopenia at the age of 39 years. |
| TextSentencer_T5 | 606-771 | Sentence | denotes | In 2007 when she was 43 years old, she developed lupus nephritis (LN) with elevated serum anti-double stranded DNA antibodies and urine protein of less than 1 g/day. |
| TextSentencer_T6 | 772-894 | Sentence | denotes | Combination therapy for the LN with 35 mg/day prednisolone and intravenous cyclophosphamide (IVCY) led to renal remission. |
| TextSentencer_T7 | 895-972 | Sentence | denotes | After the seventh monthly session of IVCY, she developed dyspnea on exertion. |
| TextSentencer_T8 | 973-1305 | Sentence | denotes | PAH was diagnosed based on enlarged main pulmonary arteries on the chest x-ray, right ventricular outflow and a peak tricuspid regurgitant pressure gradient exceeding 45 mmHg on echocardiography, an elevated plasma brain natriuretic peptide (BNP) level of 260 pg/ml, the exclusion of pulmonary thromboembolism, and no lung fibrosis. |
| TextSentencer_T9 | 1306-1353 | Sentence | denotes | The PAH was treated successfully with bosentan. |
| TextSentencer_T10 | 1354-1450 | Sentence | denotes | At present the tricuspid regurgitation has disappeared, and the plasma BNP level has normalized. |
| T1 | 0-138 | Sentence | denotes | [Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis]. |
| T2 | 139-306 | Sentence | denotes | We report a 43-year-old female who developed pulmonary arterial hypertension (PAH) during intensive immunosuppressive therapy for systematic lupus erythematosus (SLE). |
| T3 | 307-442 | Sentence | denotes | She was diagnosed as SLE at the age of 32 years based on serological and hematological abnormalities, oral ulcers, and facial erythema. |
| T4 | 443-605 | Sentence | denotes | She experienced frequent flare-ups of disseminated discoid lupus between the ages of 33 and 36 years and developed immune thrombocytopenia at the age of 39 years. |
| T5 | 606-771 | Sentence | denotes | In 2007 when she was 43 years old, she developed lupus nephritis (LN) with elevated serum anti-double stranded DNA antibodies and urine protein of less than 1 g/day. |
| T6 | 772-894 | Sentence | denotes | Combination therapy for the LN with 35 mg/day prednisolone and intravenous cyclophosphamide (IVCY) led to renal remission. |
| T7 | 895-972 | Sentence | denotes | After the seventh monthly session of IVCY, she developed dyspnea on exertion. |
| T8 | 973-1305 | Sentence | denotes | PAH was diagnosed based on enlarged main pulmonary arteries on the chest x-ray, right ventricular outflow and a peak tricuspid regurgitant pressure gradient exceeding 45 mmHg on echocardiography, an elevated plasma brain natriuretic peptide (BNP) level of 260 pg/ml, the exclusion of pulmonary thromboembolism, and no lung fibrosis. |
| T9 | 1306-1353 | Sentence | denotes | The PAH was treated successfully with bosentan. |
| T10 | 1354-1450 | Sentence | denotes | At present the tricuspid regurgitation has disappeared, and the plasma BNP level has normalized. |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 1188-1193 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T2 | 1291-1295 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| PD-UBERON-AE-B_T3 | 52-60 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
| PD-UBERON-AE-B_T4 | 194-202 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
| PD-UBERON-AE-B_T5 | 1024-1032 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arteries |
| PD-UBERON-AE-B_T6 | 1040-1045 | http://purl.obolibrary.org/obo/UBERON_0001443 | denotes | chest |
| PD-UBERON-AE-B_T7 | 690-695 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T8 | 42-60 | http://purl.obolibrary.org/obo/UBERON_0002012 | denotes | pulmonary arterial |
| PD-UBERON-AE-B_T9 | 184-202 | http://purl.obolibrary.org/obo/UBERON_0002012 | denotes | pulmonary arterial |
| PD-UBERON-AE-B_T10 | 1014-1032 | http://purl.obolibrary.org/obo/UBERON_0002012 | denotes | pulmonary arteries |
| PD-UBERON-AE-B_T11 | 736-741 | http://purl.obolibrary.org/obo/UBERON_0001088 | denotes | urine |